Pleasanton, CA, United States of America

Jaya Rajamani

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jaya Rajamani in Gene Fusion Detection

Introduction

Jaya Rajamani is an accomplished inventor based in Pleasanton, CA (US). He has made significant contributions to the field of molecular diagnostics, particularly in the detection of gene fusions. His work has implications for cancer research and treatment, showcasing the importance of innovation in medical technology.

Latest Patents

Jaya Rajamani holds a patent for "Multiplex PCR detection of ALK, RET, and ROS fusions." This patent provides methods and compositions for multiplex detection of a large number of actionable gene fusions with very high sensitivity and specificity. The present methods and compositions can detect ALK, RET, and ROS1 gene fusions, optionally in combination with other mutations and fusions. This innovation represents a significant advancement in the ability to diagnose and treat various cancers.

Career Highlights

Throughout his career, Jaya Rajamani has worked with notable companies in the biotechnology sector. He has been associated with Roche Molecular Systems, Inc. and Roche Diagnostics GmbH, where he contributed to the development of cutting-edge diagnostic technologies. His expertise in molecular biology and diagnostics has positioned him as a key player in the industry.

Collaborations

Jaya Rajamani has collaborated with talented professionals in his field, including Ann Begovich and Cindy Cheung. These collaborations have fostered an environment of innovation and have led to advancements in molecular diagnostics.

Conclusion

Jaya Rajamani's contributions to gene fusion detection exemplify the impact of innovation in healthcare. His patent and career achievements highlight the importance of continued research and development in the field of molecular diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…